The Impact of Arts-Based Interventions on Patient Hospital Experience

July 9, 2024 updated by: Kimberly Kirklin, University of Alabama at Birmingham

The Impact of Arts-Based Interventions on Patient Hospital Experience for Patients on a High-Risk Obstetrics and Bone Transplant Units

nuts and bolts

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

interventions and timing of interventions

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion:

  • Inpatient on either Bone Marrow Transplant ICU or High Risk Obstetrics Unit
  • Estimated length of stay 2 or more weeks
  • Age >18
  • Patients who will potentially benefit from the AIM experience

Additional Inclusion Criteria:

  • For the High Risk Obstetrics Unit group (hand-sewing), patients should be physically able to participate in hand-sewing activity.
  • For the Bone Marrow Transplant IUC group (story-telling/poetry), patients should be physically able to participate in story-telling/poetry activity.

Exclusion:

  • Patient too ill
  • Complex medical condition that requires therapies which would not allow time for participation
  • Declined to participate
  • Age <18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patients on a high-risk obstetrics unit with an anticipated stay of two or more weeks
patients in this group will receive twice weekly sewing and embroidery interactions with a professional artist in residence.
If selected for the arts activity, an artist in residence will visit you 3 times a week for a total of 3 weeks during your hospital stay. Two visits will focus on the arts activity and one visit will be the administration of the questionnaire. Each visit will be approximately 25 minutes at a time.
Active Comparator: Patients on a bone marrow transplant unit with an anticipated stay of two or more weeks
patients in this group will receive twice weekly visits with a professional storyteller.
If selected for the arts activity, an artist in residence will visit you 3 times a week for a total of 3 weeks during your hospital stay. Two visits will focus on the arts activity and one visit will be the administration of the questionnaire. Each visit will be approximately 25 minutes at a time.
No Intervention: HRO Standard of Care
SOC
No Intervention: BMT Standard of Care
SOC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate patient experience during the course of intervention using name of survey
Time Frame: Baseline at admissions
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
Baseline at admissions
Evaluate patient experience during the course of intervention using name of survey
Time Frame: Baseline - end of week 1
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
Baseline - end of week 1
Evaluate patient experience during the course of intervention using name of survey
Time Frame: week 1- week 2
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
week 1- week 2
Evaluate patient experience during the course of intervention using name of survey
Time Frame: week 2 - week 3
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
week 2 - week 3
Evaluate patient experience during the course of intervention using name of survey
Time Frame: week 3 - weekly up to 10 weeks
define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best
week 3 - weekly up to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kimberly P Kirklin, MA, University of Alabama at Birmingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

April 25, 2019

First Submitted That Met QC Criteria

July 17, 2019

First Posted (Actual)

July 18, 2019

Study Record Updates

Last Update Posted (Actual)

July 10, 2024

Last Update Submitted That Met QC Criteria

July 9, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-300001347
  • UL 1 TR003096 (Other Grant/Funding Number: Foundation for Orthopaedic Trauma)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

At this time we do not have IRB approval to share IPD. We may change this in the future.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on High Risk Pregnancy

Clinical Trials on Arts Intervention

Subscribe